KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer
Impact in
- Oncology 1.3k
Classified as
- Journal
- Cancer Research
In The Last Decade
doi.org/10.1158/0008-5472.can-06-0191 →Countries where authors are citing KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer
This map shows the geographic impact of KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer more than expected).
Fields of papers citing KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer
This network shows the impact of KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer.
About KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer
This paper, published in 2006, received 1.9k indexed citations . Written by Astrid Lièvre, Jean‐Baptiste Bachet, Delphine Le Corre, Valérie Boige, Bruno Landi, Jean‐François Emile, Jean‐François Côté, Gorana Tomasic, Christophe Penna and Michel Pierre Ducreux covering the research area of Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine. It is primarily cited by scholars working on Oncology (1.3k citations), Pulmonary and Respiratory Medicine (451 citations), Molecular Biology (406 citations), Pathology and Forensic Medicine (395 citations) and Cancer Research (390 citations). Published in Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1158/0008-5472.can-06-0191.